Equity
€811,185 =
BARAMED paid out €170,058 in dividends. That is 100% of the 2025 profit.
BARAMED
Lifetime
8 annual accounts with figures on one time axispeak €255,431 (2025)
€255,431▲ 11.1%
peak €170,058 (2025)
€170,058▲ 38.5%
peak €811,185 (2024)
€811,185unchanged
€207,656▲ 615%
peak 0.7 FTE (2019)
-not published
Board2 names since 2017
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Result from €122,779 to €170,058Dividend €170,058Debts from €29,024 to €207,656Investments €72,315
Key points
from the 2025 annual accountsDebts
€207,656 ▲ 615%
Debts rose by €178,631 in 2025.
Investments
€73,462 6.3 × depreciation
Green is investment, beige is depreciation. Machinery stands 791.6% higher than in 2024.
Liquidity
4.18 was 25.80 in 2024
Short-term debts rose from €29,024 to €207,347.
Filings
8 annual accounts since 2018
The last five annual accounts were filed 3 to 31 days before the end of the period.
Position in the sector
€811,185
More equity than 90% of companies in human health. Sector median €125,045 · 21,332 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,973 companies had the same profile as BARAMED has now. Each dot stands for 68 companies, two years later.
94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for BARAMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0681462216
Resignation: (manager)
Reappointment: (director) · Director discharge: · General meeting of 27-03-2023 · Gazette deed
2 establishments registered
Dilsen-Stokkem
Incorporation
Founding capital of €18,600, 100 shares, €12,400 paid up · Founder: · Appointment: (manager) · published on 27-09-2017 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BARAMED Dilsen-Stokkem | €1.0m | €255,431 | 79.6% | - |
| DOKTER GULIKERS Maasmechelen | €0.9m | €242,441 | 77.0% | - |
| AMJ United Hasselt | €0.9m | €266,562 | 43.4% | - |
| PRAKTIJK DE GELMEL Hoogstraten | €1.0m | €267,467 | 98.8% | - |
| RENAUD LIVIN MEDECIN Sivry-Rance | €1.0m | €235,230 | 40.6% | - |
| Docdico Berlaar | €0.9m | €247,911 | 2.1% | - |
| SOMFRANC COMPANY Namur | €0.9m | €257,586 | 75.5% | - |
These companies have the same main activity as BARAMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €891,000 and €1m, founded between 2016 and 2018.
Official details
Source: KBO- Status
- Active since 07-09-2017Normal situation
- Activity
- General medical practiceNACE 86210and 1 other
- Joint committee
- 330.04Health institutions and services · annual accounts 2025
- Establishment units
- 2.268.149.6143650 Dilsen-Stokkem, since 18-09-2017
- 2.268.367.7643650 Dilsen-Stokkem, since 18-09-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 06-03-2025
Annual accounts 2025
- ≈ €390,000estimated
- €1.0m▲ 21.3%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on BARAMED
BARAMED files the micro format. That format states no turnover. The gross margin rose from €191,434 in 2018 to €255,431 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BARAMED
- What is the company number of BARAMED?
- The company number of BARAMED is 0681.462.216. The VAT number is the same number with BE in front: BE 0681.462.216.
- Where is BARAMED based?
- The registered office is at Bloemendaal 15, 3650 Dilsen-Stokkem.Company details
- What does BARAMED do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of BARAMED?
- BARAMED is a private limited company (BV).
- When was BARAMED founded?
- BARAMED was founded on 07-09-2017.
- Is BARAMED still active?
- Yes, BARAMED is an active enterprise in the KBO register.
- How many employees does BARAMED have?
- BARAMED had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does BARAMED fall under?
- In its 2025 annual accounts, BARAMED states joint committee 330.04 (Health institutions and services).
- What is the turnover of BARAMED?
- The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €255,431 and 38 comparable companies (NACE 862). It probably lies between €340,000 and €490,000.
- Is BARAMED profitable?
- In financial year 2025, BARAMED made a profit of €170,058.
- Where can I find the annual accounts of BARAMED?
- BARAMED filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BARAMED due?
- BARAMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.